Epstein-Barr virus (EBV) infection is transmitted by saliva and is a major cause of cancer in people living with HIV/AIDS as well as in the general population. To better understand the determinants of oral EBV shedding we evaluated the frequency and quantity of detectable EBV in the saliva in a prospective cohort study of 85 adults in Uganda, half of whom were co-infected with HIV-1. Participants were not receiving antiviral medications, and those with HIV-1 co-infection had a CD4+ T cell count >200 cells/mm 3 . Daily, self-collected oral swabs were collected over a 4-week period. Compared with HIV-1 uninfected participants, co-infected participants had an increased frequency of oral EBV shedding (IRR=1.27, 95% CI=1.10-1.47). To explain why EBV oral shedding is greater in HIV-1 co-infected participants, we developed a stochastic, mechanistic mathematical model that describes the dynamics of EBV, infected cells, and antiviral cellular immune responses within the tonsillar epithelium, and examined
Introduction 1
Epstein-Barr virus (EBV) infection is associated with the development of approximately cells produce large numbers of infectious virions [10], facilitating latent infection of
expression of only a small number of latent gene products [11, 12] . Viral shedding is 19 highest during primary EBV infection but remains frequent throughout chronic 20 infection [5] . During chronic infection, B cells latently infected with EBV can return to 21 Waldeyer's ring, encounter cognate antigen, and become activated to mature into 22 plasma cells, triggering lytic reactivation and production of infectious virions [13] [14] [15] . 23 This process initiates a new round of epithelial infection in the tonsils and viral 24 shedding in the saliva. Increased EBV shedding with HIV-1 co-infection may be due to 25 more frequent reactivation of EBV-infected B cells, and thus increased viral seeding of 26 oral tissue, and/or impaired T cell-mediated immune control of EBV replication, 27 prolonging or inhibiting the clearance of infected epithelial cells [16] [17] [18] . 28 The dynamics of chronic herpesvirus infections in humans have been elucidated by 29 longitudinally sampling mucosal surfaces and blood, revealing the patterns of latency, 30 reactivation, and dissemination, as well as giving insight into viral pathogenesis and 31 host-pathogen interactions [19, 20] . While several studies have examined EBV mucosal 32 shedding patterns in HIV-1-infected persons [5, [21] [22] [23] [24] [25] , the majority have been in the 33 setting of advanced HIV-1 infection or in persons receiving highly active antiretroviral 34 therapy (HAART) [23] [24] [25] . The mechanisms by which co-infection with HIV-1 35 significantly increases viral loads in saliva have not been explained in part due to the 36 requirement for frequent quantitative measures of shedding amenable to mathematical 37 modelling [23] [24] [25] . Previous mathematical models have examined the within-host 38 40 parameter values for the rates at which infection dynamics occur in the tonsillar 41 epithelium [10, [26] [27] [28] [29] [30] . However, none have examined the differences between EBV 42 shedding in HIV-1 co-infected and HIV-1 uninfected individuals. In this study, we 43 analysed rich oral EBV shedding data from a cohort of Ugandan adults with or without 44 HIV-1 co-infection and constructed a mechanistic mathematical model to identify the 45 determinants of EBV replication. 46 
dynamics of EBV infection, developing quantitative descriptions of how infected cells, B 39 cells, antibodies, virus, and T cells interact, and determining biologically relevant

Results
47
HIV-1 infection is associated with increased frequency and 48 quantity of oral EBV shedding 49 Among this cohort of 85 participants, a total of 2264 daily oral swabs were collected, 50 with a median of 29 swabs per participant (range 1-32). 43 (51%) participants were 51 HIV-1 seropositive. Additional details of the cohort have been previously published [31] , 52 and other data from the cohort, including EBV loads in genital swabs and plasma 53 samples, can be found in the Supporting Information. We began our analysis by first 54 examining whether HIV-1 infection status affects the frequency of EBV detection in the 55 saliva. We found that HIV-1 infection was significantly associated with EBV detection 56 in oral swabs, increasing the frequency of observation 1.27-fold (CI = 1.10-1.47, p-value 57 = 0.001, Fig 1A) and increasing the median quantity of EBV detected in oral swabs by 58 1 .61 log 10 genome copies (CI = 1.29-1.93, p-value <0.001, Fig 1B) . We also saw large magnitude (range 0.34-5.27, IQR 1.32) within individual HIV-1 uninfected participants 65 and a median of 2.30 orders of magnitude (range 0.95-5.93, IQR 1.15) within individual 66 HIV-1 co-infected participants.
67
The effect of CD4+ T count and HIV-1 plasma RNA levels on 68 oral EBV shedding in HIV-1 co-infected individuals 69 We next analysed how CD4+ T cell counts and HIV-1 plasma RNA levels impacted the 70 frequency of EBV detection in oral swabs of HIV-1 infected participants (Table 1) .
71
CD4+ T cell count significantly affected the frequency of EBV detection in oral swabs. 72 Each additional 100-cell increase in CD4+ T cells/mm 3 was associated with a 5% 73 reduction in the odds of EBV detection. This is consistent with cell-mediated immunity 74 conferring partial but incomplete control of EBV replication. We found no significant 75 association between HIV-1 viral load in plasma and the frequency of EBV detection in 76 saliva.
77 Table 1 . Effects of plasma HIV-1 load and CD4+ T cell count on the frequency of EBV detection. 
95
The dynamics within each crypt are shown in Fig 2. All parameters were assumed to 96 remain constant over the course of study, with some varying between participants to 97 account for differences in EBV shedding and HIV-1 infection status. We assumed that 98 latently infected B cells reactivate and infect the epithelium at a constant rate b.
99
Infected epithelial cells, I, infect other epithelial cells through cell-to-cell contact at a 100 constant per-capita rate β. As the total number of cells within a single crypt is large in 101 comparison to the expected number that can become infected with EBV, we assumed 102 that target cell number is not limiting. Epithelial infection causes the recruitment and 103 proliferation of EBV-specific cytotoxic T cells, T , at a per-capita rate θI. Cytotoxic T 104 cells kill infected epithelial cells following the law of mass action at a rate f IT . We 105 assumed that cytotoxic T cells die or leave the tonsils at a per-capita rate δ.
106
Independent of infection, we assumed a constant number of EBV-specific cytotoxic T infection is caused by cell-to-cell contact [10, 35] .
119
The concentration of EBV detected in the saliva of participants was highly variable, 120 and frequently undetectable. Therefore, we chose to implement our model in a I → I + 1 with rate b + βI (1)
T → T + 1 with rate θI(T + α)
T → T − 1 with rate δT (4)
V → V − 1 with rate cV. 
Basic model analysis
125
To understand how the different parameters of our mathematical model affect simulated 126 EBV shedding in saliva, we first conducted a literature review to find previously 127 estimated or measured values of our parameters ( agreed with published estimates. We allowed b and θ to vary during fitting as these two 148 parameters are the most likely to be affected by HIV-1 infection status. parameter values that produced simulations with similar summary statistics to the data 154 rather than simulations that directly matched the curve of the data. The traits of each 155 participant were captured using five summary statistics: the percentage of EBV-positive 156 swabs, the median, maximum, and variance of detectable viral loads, and the number of 157 peaks in viral load, a peak being defined as when the directly preceding and following 158 time points have lower viral loads. The goodness of fit was assessed by the statistic ρ i,j , 159 which is defined as
for participant i and parameter set j. Here D i,k is the k th summary statistic for the 161 data of participant i andD j,k is the k th summary statistic for simulations using Among all 85 participants' data, we were able to fit parameters to 82. participants, the median ρ value generated from parameter sets was higher and, 187 therefore, a worse fit than our fixed parameter choices, providing confidence that the 188 values chosen for our fixed parameters provided a consistently good fit.
189
Fig 6. Sensitivity analysis of fit parameters. For the 1000 parameter sets selected by the ABC fitting algorithm for each participant, we varied parameters β, f , α, δ, p, and c (the parameters that remained fixed during fitting) over two orders of magnitude to observe whether changes in these values could have improved the model fit. Each parameter was set to equal 0.1 and 10 times the value it was set to during fitting and one simulation of each new parameter set was performed. The median factor-change in the resulting ρ value for each participant is shown on the y-axis. In all cases, the new parameter values led to worse fits (factor change in ρ exceeded one).
High EBV viral loads are caused by large numbers of actively producing virus at the same time (Fig 7) . Using importance sampling (Methods) on the 194 results of our ABC fitting algorithm, we achieved a representation of how the number of 195 actively infected crypts and the amount of virus produced by these crypts differ among 196 individuals stratified by HIV-1 infection status.
197
The distributions for the median number of crypts HIV-1 co-infected and HIV-1 individual with probability 0.65 ( Fig 7C) . numbers of actively infected crypts (Fig 7B) and higher viral loads per actively infected 219 crypt (Fig 7D) . Together, these results indicate that high EBV loads in the saliva are 220 caused by more frequent and extensive infection in tonsillar crypts. This trend translates to HIV-1 co-infected participants having more infected crypts infected, and each infected crypt producing more virus. Bars above boxplots indicate the probability that a randomly selected individual of one group has a higher parameter value (be it number of active crypts or viral load/active crypt) than a randomly selected individual in a second group. Arrows show the direction of comparison. We see that HIV-1 uninfected individuals usually have more actively infected crypts and more virus per active crypt than HIV-1 co-infected individuals. Similarly, we see that individuals with higher median viral loads in their saliva usually have more actively infected crypts and more virus per active crypt than individuals with lower median viral loads.
Greater oral EBV shedding in HIV-1 co-infection is due to between the strength of the EBV-specific cytotoxic T cell immune response (θ) and the 246 median viral load (Fig 8B and 8D ).
247
We also sought to quantify the correlation between b and θ (Fig 9) . When looking at 248 within-group correlation of participants with similar median viral loads, b and θ have Fitting our mathematical model to participant data revealed that parameter b is usually greater in HIV-1 co-infected participants (A) and increases with median EBV viral load (B), and parameter θ is usually lower in HIV-1 co-infected participants (C) and decreases with median saliva EBV viral load (D). Bars above boxplots indicate the probability that a randomly selected individual of one group has a higher parameter value (be it b or θ) than a randomly selected individual in a second group. Arrows show the direction of comparison. We next examined whether rates of B cell reactivation and cellular immune response 255 could be predicted by the CD4+ T cell count and HIV-1 plasma viral load in HIV-1 256 co-infected participants. A generalized linear model (Methods) revealed that each log 10 257 increase in HIV-1 RNA copies/ml significantly decreased the value of θ but did not 258 significantly affect b. However, each 100-cell/mm 3 increase in CD4+ T cell count 259 significantly changed the value of θ and b, increasing θ and decreasing b (Table 3 ). To test it's generalizability, we applied our model to a previously described set of data 263 from a cohort of 26 participants in Seattle, Washington, who underwent daily oral EBV 264 sampling and testing using the same methods as the Ugandan cohort described 265 above [22] . A total of 1323 swabs were collected during the 8-week period of the study, 266 with a median of 55 swabs per participant (3-61 swabs). 16 (62%) of these participants 267 were HIV-1 co-infected and if on HAART were required to remain on a stable regimen 268 throughout the study. None were receiving other antiviral drugs at the time of 269 enrollment. While the objective of the Seattle study was to analyse the effects of 270 valganciclovir on daily EBV oral shedding, we restricted our analysis to the data from 271 the eight-week period when participants received placebo. It has been previously reported that persons infected with HIV-1 have higher oral
260
294
EBV shedding than HIV-1 uninfected individuals [3, 4, 23-25, 42, 43] . However, few data 295 sets allow detailed representation of the dynamics of oral EBV shedding in HIV-1 296 co-infected and uninfected participants over time. We also found that HIV-1 infection 297 was associated with a significantly increased frequency and quantity of oral EBV 298 shedding. There was also a statistically significant association between higher CD4+ T 299 cell counts and a lower frequency of EBV shedding in HIV-1 co-infected participants.
300
B cell activation and plasma cell differentiation have been shown to induce EBV 301 reactivation and lytic replication [12] . Furthermore, it is clear that HIV-1 infection is 302 associated with increased levels of B cell activation [18, 44] . As such, we hypothesized immune response within the tonsillar epithelium. We then fit this model to participant 308 data, seeking to determine the drivers of these differences.
309
While previous mathematical models have examined the within-host dynamics of 310 EBV infection [10, [26] [27] [28] [29] , none have examined the differences between HIV-1 infected 311 and HIV-1 uninfected individuals [38, [45] [46] [47] . Strengths of our approach include the [38, [45] [46] [47] . These previous models all captured the stochastic patterns 323 of HSV-2 shedding well, which appear similar to the patterns of oral EBV shedding.
324
Our model assumes that all tonsillar crypts are independent from one another. In 325 reality, virus from one infected crypt may spill over and seed infection in a neighbouring 326 crypt, rather than EBV entering an uninfected crypt purely via the reactivation of B 327 cells as we assume in our model. By not accounting for this, our predicted B cell 328 reactivation rates are likely higher than their true biological values. However, assuming 329 the amount of viral spill-over into neighbouring crypts is proportional to the viral load, 330 our qualitative comparison remains valid. Furthermore, modelling the tonsillar crypts as 331 multiple, segregated sites of infection was essential for simulating the high variability in 332 viral load seen over time in cohort data. In simulations without this spatial separation, 333 viral loads and levels of immune surveillance within an individual often equilibrated over 334 time and no longer matched the stochastic nature of participant data. This result [17, 18, 49, 50] . Indeed, our model demonstrated that higher CD4+ T cell 353 counts were associated with significantly higher predicted rates of EBV-specific 354 cytotoxic T cell activity and significantly lower predicted rates of EBV-infected B cell 355 reactivation. Furthermore, increases in HIV-1 plasma RNA levels were associated with 356 significantly lower predicted rates of EBV-specific cytotoxic T cell activity.
357
Importantly quantitative polymerase chain reaction (qPCR) was performed using specific primers to 394 detect EBV [60] , with positive and negative controls as previously described [19, 59] .
395
Mucosal samples with greater than 150 copies/ml and plasma samples with greater than 396 50 copies/ml herpesvirus DNA/ml were considered positive [61] .
397
Statistical analyses of data
398
The frequency of mucosal shedding and viremia was defined as the proportion of 
and crypt c's dynamics are taken from the time interval 
425
Viral loads from each crypt are added together to get the model-predicted amount of 426 virus seen in the saliva over time. As the qPCR threshold of detection was 150 427 copies/ml for the data used, whenever the total simulated viral load in the saliva 428 dropped below 150 copies/ml, we set the output to zero.
429
Model fitting using Approximate Bayesian Computation
430
We next fit parameters to daily quantitative oral EBV shedding data from our cohort 
where D i,k is the k th summary statistic for the data of participant i andD j,k is the k We combined the results of our ABC fitting algorithm to compare how the posterior 465 distributions of parameters b and θ, the number of actively infected crypts, and the 466 amount of virus produced vary between different participant groups.
467
As some parameter values selected by the ABC fitting algorithm fit the data better 468 than others (i.e. have lower ρ values), we approximated the posterior distributions of 
Note that 
We took 10 5 draws from each distribution and plotted the resulting data to obtain 481 graphical representations of the posterior parameter distributions for parameters b and 482 θ, the number of actively infected crypts, and the virus produced, for HIV-1 co-infected 483 and uninfected participants. The above process was repeated where instead of 484 stratifying by HIV-1 status, participants were stratified by median EBV load in order to 485 produce similar plots.
486
We also performed importance sampling on the raw posterior distributions for 487 individual participants. Using these, we were able to calculate the mean parameter analysis we selected parameter values for β, f , α, δ, p, and c which would remain fixed 501 throughout the ABC data fitting process while leaving the parameters of most interest, 502 b and θ, free.
503
After completing ABC, we performed another univariate analysis to observe whether 504 our choices for fixed parameter values were correct. By letting b and θ equal values 505 selected by the ABC algorithm and then individually varying the parameters that were 506 fixed, we checked whether different values of our fixed parameters would have improved 507 the model's fit. 
